1-3 of 3
Authors: Beth Overmoyer
Sort by
Journal Article
Abnormal vascular structure and function within brain metastases is linked to pembrolizumab resistance Free
Albert E Kim and others
Neuro-Oncology, Volume 26, Issue 5, May 2024, Pages 965–974, https://doi.org/10.1093/neuonc/noad236
Published: 09 December 2023
Journal Article
CTIM-02. PHASE 2 TRIAL OF PEMBROLIZUMAB FOR PATIENTS WITH BRAIN METASTASES OF DIVERSE HISTOLOGIES Free
Priscilla Brastianos and others
Neuro-Oncology, Volume 25, Issue Supplement_5, November 2023, Pages v60–v61, https://doi.org/10.1093/neuonc/noad179.0242
Published: 10 November 2023
Journal Article
CTIM-02. PHASE II STUDY OF IPILIMUMAB AND NIVOLUMAB IN LEPTOMENINGEAL CARCINOMATOSIS Free
Matthew Strickland and others
Neuro-Oncology, Volume 23, Issue Supplement_6, November 2021, Page vi49, https://doi.org/10.1093/neuonc/noab196.194
Published: 12 November 2021